Antimicrobial Efficacy of Photodynamic Therapy as an Adjunct to Brix 3000 in Minimally Invasive Management of Carious Lesions in Primary Teeth
Abstract
1. Introduction
2. Results
2.1. Microbial Profile of Infected Dentin Prior to Excavation (Sample 1)
2.2. Microbial Profile of Partially Infected Dentin After Brix 3000 Excavation (Sample 2)
2.3. Microbial Profile After Photodynamic Disinfection (Sample 3, Group 2)
2.4. Representative Clinical Case
3. Discussion
4. Materials and Methods
4.1. Study Design and Ethical Considerations
4.2. Study Population and Inclusion Criteria
4.3. Group Allocation
- -
- Group 1 (control group): 15 children treated with chemo-mechanical caries removal using Brix 3000 only.
- -
- Group 2 (experimental group): 15 children treated with chemo-mechanical caries removal using Brix 3000, followed by an additional antimicrobial photodynamic disinfection procedure using the FotoSan630 Intro Kit.
4.4. Inclusion and Exclusion Criteria
4.5. Clinical Procedures
4.5.1. Chemo-Mechanical Caries Removal with Brix 3000—Group 1 (Control Group)
4.5.2. Chemo-Mechanical Caries Removal with Brix 3000 and PDT—Group 2 (Experimental Group)
4.6. Fluorescence-Guided Assessment
- -
- Infected dentin: Intense red or dark red fluorescence covering the entire carious dentin area;
- -
- Partially infected dentin: Pink fluorescence with localized, limited red areas in the peripulpal dentin zone;
- -
- Affected dentin: Pale pink fluorescence localized to isolated areas of the cavity floor, with no fluorescence in the remaining cavity.
4.7. Microbiological Methods
- -
- Thirty samples from infected dentin prior to excavation with Brix 3000 (Groups 1 and 2);
- -
- Thirty samples from partially infected dentin after excavation with Brix 3000 (Groups 1 and 2);
- -
- Fifteen samples collected after additional photodynamic disinfection with the FotoSan 630 Intro Kit (Group 2 only).
4.8. Statistical Analysis
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| PDT | Photodynamic Therapy |
| ICDAS II | International Caries Detection and Assessment System II |
| CFU | Colony-Forming Unit |
| CFU/mL | Colony-Forming Units per Milliliter |
| LED | Light-Emitting Diode |
| B.E.K. | Buffered Emulsion for Encapsulation |
| EVE | Enzyme Vehicle Encapsulation |
References
- Sahebalam, R.; Ghorbani, M.; Shirazi, A.S.; Khosrojerdi, M.; Mowji, M. Comparative success of minimally invasive treatments for cavitated carsies in primary teeth: A network meta-analysis. BMC Oral Health 2025, 25, 1469. [Google Scholar] [CrossRef]
- Galvan Cortes, I.G.; Sanchez Najera, R.I.; Roesch Ramos, L.; Moreno Marin, F.; Olivas Velazquez, A.K.; Rocha Lopez, A.; Viezca Villarreal, A.; Solis Soto, J.M. Minimally invasive pediatric dentistry: Management of carious lesions in primary teeth—A review. Int. J. Appl. Dent. Sci. 2025, 11, 43–46. [Google Scholar] [CrossRef]
- Han, S.-Y.; Chang, C.-L.; Wang, Y.-L.; Wang, C.-S.; Lee, W.-J.; Vo, T.T.; Chen, Y.-L.; Cheng, C.-Y.; Lee, I.-T. A Narrative Review on Advancing Pediatric Oral Health: Comprehensive Strategies for the Prevention and Management of Dental Challenges in Children. Children 2025, 12, 286. [Google Scholar] [CrossRef]
- Srivastava, V.K.; Badnaware, S.; Kumar, A.; Khairnar, M.; Chandel, M.; Bhati, V.; Gupta, P.; Sonal, S.; Ramasamy, S. Prevalence of most caries-susceptible area on individual primary tooth surface: An observational study. J. Clin. Pediatr. Dent. 2024, 48, 111–120. [Google Scholar] [CrossRef]
- Janvier, A.; Maziere, M.; Rodrigues, C.F.; Lobo, A.P.; Rompante, P. Antimicrobial efficacy of chemomechanical caries removal agents: Focus on papain-based gels including BRIX3000. Biomedicines 2024, 12, 1735. [Google Scholar] [CrossRef]
- Cieplik, F.; Deng, D.; Crielaard, W.; Buchalla, W.; Hellwig, E.; Al-Ahmad, A.; Maisch, T. Antimicrobial photodynamic therapy—What we know and what we do not. Crit. Rev. Microbiol. 2018, 44, 571–589. [Google Scholar] [CrossRef]
- Wilson, M.; Dobson, J. Lethal photosensitization of oral anaerobic bacteria. Clin. Infect. Dis. 1993, 16, S414–S415. [Google Scholar] [CrossRef] [PubMed]
- Soukos, N.S.; Chen, P.S.-Y.; Morris, J.T.; Ruggiero, K.; Abernethy, A.D.; Som, S.; Foschi, F.; Doucette, S.; Bammann, L.L.; Fontana, C.R.; et al. Photodynamic therapy for endodontic disinfection. J. Endod. 1996, 22, 979–984. [Google Scholar] [CrossRef] [PubMed]
- Wainwright, M.; Maisch, T.; Nonell, S.; Plaetzer, K.; Almeida, A.; Tegos, G.P.; Hamblin, M.R. Photoantimicrobials—Are we afraid of the light? Lancet Infect. Dis. 2017, 17, e49–e55. [Google Scholar] [CrossRef]
- Garcez, A.S.; Núñez, S.C.; Azambuja, N., Jr.; Fregnani, E.R.; Rodriguez, H.M.H.; Hamblin, M.R.; Suzuki, H.; Ribeiro, M.S. Effects of photodynamic therapy on Gram-positive and Gram-negative bacterial biofilms by bioluminescence imaging and scanning electron microscopic analysis. Photomed. Laser Surg. 2013, 31, 519–525. [Google Scholar] [CrossRef]
- Maisch, T. Anti-microbial photodynamic therapy: Useful in the future? Lasers Med. Sci. 2007, 22, 83–91. [Google Scholar] [CrossRef]
- Alves, L.V.G.L.; Curylofo-Zotti, F.A.; Borsatto, M.C.; de Souza Salvador, S.L.; Valério, R.A.; Souza-Gabriel, A.E.; Corona, S.A.M. Influence of antimicrobial photodynamic therapy in carious lesion: Randomized split-mouth clinical trial in primary molars. Photodiagnosis Photodyn. Ther. 2019, 26, 124–130. [Google Scholar] [CrossRef]
- Azizi, A.; Shademan, S.; Rezai, M.; Rahimi, A.; Lawaf, S. Effect of photodynamic therapy with two photosensitizers on Streptococcus mutans: An in vitro study. Photodiagnosis Photodyn. Ther. 2016, 16, 66–71. [Google Scholar] [CrossRef]
- DeRosa, M.C.; Crutchley, R.J. Photosensitized singlet oxygen and its applications. Coord. Chem. Rev. 2002, 233, 351–371. [Google Scholar] [CrossRef]
- Araújo, P.V.; Correia-Silva, J.F.; Gomez, R.S.; Massara, M.L.A.; Cortes, M.E.; Poletto, L.T.A. Antimicrobial effect of photodynamic therapy in carious lesions in vivo, using culture and real-time PCR methods. Photodiagnosis Photodyn. Ther. 2015, 12, 401–407. [Google Scholar] [CrossRef] [PubMed]
- Hamblin, M.R. Antimicrobial photodynamic inactivation: A bright new technique to kill resistant microbes. Curr. Opin. Microbiol. 2016, 33, 67–73. [Google Scholar] [CrossRef] [PubMed]
- de Oliveira, A.B.; Ferrisse, T.M.; Marques, R.S.; de Annunzio, S.R.; Brighenti, F.L.; Fontana, C.R. Effect of Photodynamic Therapy on Microorganisms Responsible for Dental Caries: A Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 2019, 20, 3585. [Google Scholar] [CrossRef]
- Scherer, K.M.; Bisby, R.H.; Botchway, S.W.; Parker, A.W. New approaches to photodynamic therapy from types I, II and III to type IV using one or more photons. Anti-Cancer Agents Med. Chem. 2017, 17, 171–189. [Google Scholar] [CrossRef]
- Konopka, K.; Goslinski, T. Photodynamic therapy in dentistry. J. Dent. Res. 2007, 86, 694–707. [Google Scholar] [CrossRef] [PubMed]
- Fiegler-Rudol, J.; Skaba, D.; Truchel, D.; Misiołek, M.; Wiench, R. Effectiveness of natural photosensitizers in antimicrobial photodynamic therapy within dentistry: A systematic review of RCTs. J. Clin. Med. 2025, 14, 8894. [Google Scholar] [CrossRef]
- Takahashi, T.; Sato, F.; Shinkai, K. The effects of antimicrobial photodynamic therapy used to sterilize carious dentin on rat dental pulp tissue. Dent. J. 2023, 11, 283. [Google Scholar] [CrossRef]
- Besegato, J.F.; Melo, P.B.G.d.; Abreu Bernardi, A.C.; Souza, M.T.; Zanotto, E.D.; Bagnato, V.S.; de Souza Rastelli, A.N. Using antimicrobial Photodynamic therapy with ultrasound devices and bioactive glasses as a combined approach for treating dentin caries lesions. Pathogens 2023, 12, 1052. [Google Scholar] [CrossRef]
- Costa-Santos, L.; Silva-Júnior, Z.S.; Sfalcin, R.A.; da Mota, A.C.C.; Horliana, A.C.R.T.; Motta, L.J.; Mesquita-Ferrari, R.A.; Fernandes, K.P.S.; Prates, R.A.; Silva, D.F.T.; et al. The effect of antimicrobial photodynamic therapy on infected dentin in primary teeth: A randomized controlled clinical trial protocol. Medicine 2019, 98, e15110. [Google Scholar] [CrossRef]
- De Gregoriis, L.; Dotta, T.C.; Petrini, M.; Di Lodovico, S.; D’Ercole, L.; D’Ercole, S.; Tripodi, D. Exploring the antimicrobial and clinical efficacy of a novel technology in pediatric endodontics: An in vivo study. Appl. Sci. 2025, 15, 6491. [Google Scholar] [CrossRef]
- Nagata, J.Y.; Hioka, N.; Kimura, E.; Batistela, V.R.; Terada, R.S.S.; Graciano, A.X.; Baesso, M.L.; Hayacibara, M.F. Antibacterial photodynamic therapy for dental caries: Evaluation of the photosensitizers used and light source properties. Photodiagnosis Photodyn. Ther. 2012, 9, 122–131. [Google Scholar] [CrossRef]
- Soria-Lozano, P.; Gilaberte, Y.; Paz-Cristobal, M.P.; Pérez-Artiaga, L.; Lampaya-Pérez, V.; Aporta, J.; Pérez-Laguna, V.; García-Luque, I.; Revillo, M.J.; Rezusta, A. In vitro effect of photodynamic therapy with different photosensitizers on cariogenic microorganisms. BMC Microbiol. 2015, 15, 187. [Google Scholar] [CrossRef]
- Bjørndal, L.; Simon, S.; Tomson, P.L.; Duncan, H.F. Management of deep caries and the exposed pulp. Int. Endod. J. 2019, 52, 949–973. [Google Scholar] [CrossRef]



| Cariogenic Microorganisms | Group 1: 1 × 105–107 CFU | Group 1: 1 × 103–104 CFU | Group 1: Without Growth | Group 2: 1 × 105–107 CFU | Group 2: 1 × 103–104 CFU | Group 2: Without Growth |
|---|---|---|---|---|---|---|
| S. mutans | 13, 86.7% | 2, 13.3% | 0, 0% | 13, 86.7% | 2, 13.3% | 0, |
| S. sanguis | 3, 20% | 2, 13.3% | 10, 66.7% | 1, 6.7% | 3, 20% | 11, 73.3% |
| S. parasanguis | 2, 13.3% | 2, 13.3% | 11, 73.3% | 2, 13.3% | 3, 20% | 10, 66.7% |
| S. mitis | 4, 26.7% | 0, - | 11, 73.3% | 2, 13.3% | 1, 6.7% | 12, 80% |
| Staphylococcus epidermidis | 2, 13.3% | 2, 13.3% | 11, 73.3% | 2, 13.3% | 2, 13.3% | 11, 73.3% |
| Neisseria spp. | 2, 13.3% | 0, - | 13, 86.7% | 0, - | 1, 6.7% | 14, 93.3% |
| Actinomyces spp. | 1, 6.7% | 3, 20% | 11, 73.3% | 0, - | 3, 20% | 12, 80% |
| Lactobacillus spp. | 11, 73.3% | 3, 20% | 1, 6.7% | 10, 66.7% | 1, 6.7% | 5, 33.3% |
| Cariogenic Microorganisms | Group 1: 1 × 105–107 CFU | Group 1: 1 × 103–104 CFU | Group 1: Without Growth | Group 2: 1 × 105–107 CFU | Group 2: 1 × 103–104 CFU | Group 2: Without Growth |
|---|---|---|---|---|---|---|
| S. mutans | -, - | 13, 86.7% | 2, 13.3% | -, - | 13, 86.7% | 2, 13.3% |
| S. sanguis | -, - | 2, 13.3% | 13, 86.7% | -, - | 2, 13.3% | 13, 86.7% |
| S. parasanguis | -, - | -, - | 15, 100% | -, - | 1, 6.7% | 14, 93.3% |
| S. mitis | -, - | 4, 26.7% | 11, 73.3% | -, - | 1, 6.7% | 14, 93.3% |
| Staphylococcus epidermidis | -, - | 2, 13.3% | 13, 86.7% | -, - | 3, 20% | 12, 80% |
| Neisseria spp. | -, - | -, - | 15, 100% | -, - | 1, 6.7% | 14, 93.3% |
| Actinomyces spp. | -, - | -, - | 15, 100% | -, - | 1, 6.7% | 14, 93.3% |
| Lactobacillus spp. | -, - | -, - | 15, 100% | -, - | 1, 6.7% | 14, 93.3% |
| Cariogenic Microorganisms | Group 2: 1 × 105–107 CFU | Group 2: 1 × 103–104 CFU | Group 2: Without Growth |
|---|---|---|---|
| S. mutans | -, - | -, - | 15, 100% |
| S. sanguis | -, - | -, - | 15, 100% |
| S. parasanguis | -, - | -, - | 15, 100% |
| S. mitis | -, - | -, - | 15, 100% |
| Staphylococcus epidermidis | -, - | -, - | 15, 100% |
| Neisseria spp. | -, - | -, - | 15, 100% |
| Actinomyces spp. | -, - | -, - | 15, 100% |
| Lactobacillus spp. | -, - | -, - | 15, 100% |
| Inclusion Criteria | Exclusion Criteria |
|---|---|
| Children with written informed consent obtained from a parent or legal guardian | Children with negative behavior according to the Frankl behavior rating scale |
| Systemically healthy children | Presence of acute clinical symptoms at the time of examination |
| Children demonstrating positive behavior according to the Frankl behavior rating scale | Presence of periapical radiographic changes affecting the examined teeth |
| Absence of acute clinical symptoms at the time of examination | |
| Absence of concomitant systemic diseases | |
| Absence of periapical radiographic changes in the examined teeth |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Lazarova, Z.; Gergova, R.; Mitova, N. Antimicrobial Efficacy of Photodynamic Therapy as an Adjunct to Brix 3000 in Minimally Invasive Management of Carious Lesions in Primary Teeth. Pharmaceuticals 2026, 19, 310. https://doi.org/10.3390/ph19020310
Lazarova Z, Gergova R, Mitova N. Antimicrobial Efficacy of Photodynamic Therapy as an Adjunct to Brix 3000 in Minimally Invasive Management of Carious Lesions in Primary Teeth. Pharmaceuticals. 2026; 19(2):310. https://doi.org/10.3390/ph19020310
Chicago/Turabian StyleLazarova, Zornitsa, Raina Gergova, and Nadezhda Mitova. 2026. "Antimicrobial Efficacy of Photodynamic Therapy as an Adjunct to Brix 3000 in Minimally Invasive Management of Carious Lesions in Primary Teeth" Pharmaceuticals 19, no. 2: 310. https://doi.org/10.3390/ph19020310
APA StyleLazarova, Z., Gergova, R., & Mitova, N. (2026). Antimicrobial Efficacy of Photodynamic Therapy as an Adjunct to Brix 3000 in Minimally Invasive Management of Carious Lesions in Primary Teeth. Pharmaceuticals, 19(2), 310. https://doi.org/10.3390/ph19020310

